Growth of transgenic <i>D</i>. <i>parva</i> and control after one month. by Lingru Ruan (18995544)

Subjects:

Predicted <i>cis</i>-acting elements in <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

Subjects:

Sociodemographic, occupational, workability characteristics among diabetic workers. by Sarah A. Bolbol (21702891)

Subjects:

Contents of chlorophyll a, chlorophyll b (Chl a, Chl b) and carotenoid in <i>D</i>. <i>parva</i> cells under treatment of various concentrations of MeJA and GA3. by Lingru Ruan (18995544)

Subjects:

Fig 2 - by Lingru Ruan (18995544)

Subjects:

Sequence of <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

Subjects:

Correlation between workability and laboratory findings of diabetic workers. by Sarah A. Bolbol (21702891)

Subjects:

Amplification of <i>DpAP2</i> full-length cDNA. by Lingru Ruan (18995544)

Subjects:

Verification of transgenic <i>D</i>. <i>parva</i>. by Lingru Ruan (18995544)

Subjects:

Association between workability and laboratory findings of diabetic workers. by Sarah A. Bolbol (21702891)

Subjects:

Construction of transgenic <i>D</i>. <i>parva</i> overexpressing <i>DpAP2</i> gene. by Lingru Ruan (18995544)

Subjects:

Fig 4 - by Lingru Ruan (18995544)

Subjects:

Sociodemographic, occupational, and clinical risk factors associated with low workability and results of Logistic regression analysis among diabetic workers. by Sarah A. Bolbol (21702891)

Subjects:

Carotenoid contents of control and transgenic <i>D</i>. <i>parva</i>. by Lingru Ruan (18995544)

Subjects:

Association between workability and clinical characteristics of diabetic workers. by Sarah A. Bolbol (21702891)

Subjects:

Ozone ultrafine bubble water decreases gingipain activities in <i>Porphyromonas gingivalis</i> culture supernatant. by Mana Endo (22430706)

Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription... by Thomas Hanslmeier (19949694)

Subjects:

Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... by Thomas Hanslmeier (19949694)

Subjects:

Shares of specialist groups prescribing 1^st, 2^nd, and 3^rd antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. by Thomas Hanslmeier (19949694)

Subjects:

Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). by Thomas Hanslmeier (19949694)

Subjects: